GeneOne Life Science, Inc. (KRX:011000)
South Korea · Delayed Price · Currency is KRW GeneOne Life Science Statistics
Total Valuation
KRX:011000 has a market cap or net worth of KRW 189.57 billion. The enterprise value is 212.73 billion.
| Market Cap | 189.57B |
| Enterprise Value | 212.73B |
Important Dates
The next estimated earnings date is Thursday, November 13, 2025.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
KRX:011000 has 85.20 million shares outstanding. The number of shares has increased by 2.59% in one year.
| Current Share Class | 85.20M |
| Shares Outstanding | 85.20M |
| Shares Change (YoY) | +2.59% |
| Shares Change (QoQ) | +3.54% |
| Owned by Insiders (%) | 9.96% |
| Owned by Institutions (%) | 4.27% |
| Float | 71.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.46 |
| PB Ratio | 3.03 |
| P/TBV Ratio | 3.04 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.21 |
| EV / Sales | 6.13 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -12.03 |
Financial Position
The company has a current ratio of 0.57, with a Debt / Equity ratio of 0.41.
| Current Ratio | 0.57 |
| Quick Ratio | 0.18 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.46 |
| Interest Coverage | -14.41 |
Financial Efficiency
Return on equity (ROE) is -60.14% and return on invested capital (ROIC) is -23.23%.
| Return on Equity (ROE) | -60.14% |
| Return on Assets (ROA) | -17.81% |
| Return on Invested Capital (ROIC) | -23.23% |
| Return on Capital Employed (ROCE) | -47.42% |
| Revenue Per Employee | 846.70M |
| Profits Per Employee | -1.23B |
| Employee Count | 41 |
| Asset Turnover | 0.25 |
| Inventory Turnover | 2.91 |
Taxes
| Income Tax | -275.16M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.53% in the last 52 weeks. The beta is 0.57, so KRX:011000's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | -14.53% |
| 50-Day Moving Average | 2,326.10 |
| 200-Day Moving Average | 2,326.27 |
| Relative Strength Index (RSI) | 38.24 |
| Average Volume (20 Days) | 706,689 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:011000 had revenue of KRW 34.71 billion and -50.50 billion in losses. Loss per share was -626.90.
| Revenue | 34.71B |
| Gross Profit | -11.71B |
| Operating Income | -39.50B |
| Pretax Income | -50.77B |
| Net Income | -50.50B |
| EBITDA | -21.40B |
| EBIT | -39.50B |
| Loss Per Share | -626.90 |
Balance Sheet
The company has 2.72 billion in cash and 25.89 billion in debt, giving a net cash position of -23.16 billion or -271.87 per share.
| Cash & Cash Equivalents | 2.72B |
| Total Debt | 25.89B |
| Net Cash | -23.16B |
| Net Cash Per Share | -271.87 |
| Equity (Book Value) | 62.49B |
| Book Value Per Share | 737.75 |
| Working Capital | -18.48B |
Cash Flow
In the last 12 months, operating cash flow was -15.08 billion and capital expenditures -2.60 billion, giving a free cash flow of -17.69 billion.
| Operating Cash Flow | -15.08B |
| Capital Expenditures | -2.60B |
| Free Cash Flow | -17.69B |
| FCF Per Share | -207.60 |
Margins
Gross margin is -33.74%, with operating and profit margins of -113.78% and -145.46%.
| Gross Margin | -33.74% |
| Operating Margin | -113.78% |
| Pretax Margin | -146.25% |
| Profit Margin | -145.46% |
| EBITDA Margin | -61.64% |
| EBIT Margin | -113.78% |
| FCF Margin | n/a |
Dividends & Yields
KRX:011000 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.59% |
| Shareholder Yield | n/a |
| Earnings Yield | -26.64% |
| FCF Yield | -9.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 3, 2021. It was a forward split with a ratio of 1.5.
| Last Split Date | Dec 3, 2021 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
KRX:011000 has an Altman Z-Score of -2.31 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.31 |
| Piotroski F-Score | 2 |